These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31557262)

  • 21. Comparison of the prevalence of Crimean-Congo hemorrhagic fever virus in endemic and non-endemic Bulgarian locations.
    Gergova I; Kamarinchev B
    J Vector Borne Dis; 2013 Dec; 50(4):265-70. PubMed ID: 24499848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
    Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus in Erzincan Province, Turkey, Relationship with Geographic Features and Risk Factors.
    Cikman A; Aydin M; Gulhan B; Karakecili F; Kesik OA; Ozcicek A; Akin H; Kara M
    Vector Borne Zoonotic Dis; 2016 Mar; 16(3):199-204. PubMed ID: 26808904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroepidemiological and molecular investigations of infections with Crimean-Congo haemorrhagic fever virus in Kazakhstan.
    Abdiyeva K; Turebekov N; Dmitrovsky A; Tukhanova N; Shin A; Yeraliyeva L; Heinrich N; Hoelscher M; Yegemberdiyeva R; Shapiyeva Z; Kachiyeva Z; Zhalmagambetova A; Montag J; Dobler G; Zinner J; Wagner E; Frey S; Essbauer S
    Int J Infect Dis; 2019 Jan; 78():121-127. PubMed ID: 30522982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of Crimean-Congo hemorrhagic fever.
    Akıncı E; Bodur H; Leblebicioglu H
    Vector Borne Zoonotic Dis; 2013 Jul; 13(7):429-37. PubMed ID: 23663164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Crimean-Congo hemorrhagic fever virus in healthy population, livestock and ticks in Kosovo.
    Fajs L; Humolli I; Saksida A; Knap N; Jelovšek M; Korva M; Dedushaj I; Avšič-Županc T
    PLoS One; 2014; 9(11):e110982. PubMed ID: 25393542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
    Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
    Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in research on Crimean-Congo hemorrhagic fever.
    Papa A; Mirazimi A; Köksal I; Estrada-Pena A; Feldmann H
    J Clin Virol; 2015 Mar; 64():137-43. PubMed ID: 25453328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques.
    Hawman DW; Haddock E; Meade-White K; Nardone G; Feldmann F; Hanley PW; Lovaglio J; Scott D; Komeno T; Nakajima N; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2020 Sep; 181():104858. PubMed ID: 32645335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.
    Bente DA; Alimonti JB; Shieh WJ; Camus G; Ströher U; Zaki S; Jones SM
    J Virol; 2010 Nov; 84(21):11089-100. PubMed ID: 20739514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crimean Congo hemorrhagic fever among the one-humped camel (Camelus dromedaries) in Central Sudan.
    Suliman HM; Adam IA; Saeed SI; Abdelaziz SA; Haroun EM; Aradaib IE
    Virol J; 2017 Aug; 14(1):147. PubMed ID: 28774342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential microRNA markers related to Crimean-Congo hemorrhagic fever disease.
    Arslan S; Engin A; Aydemir EI; Sahin NO; Bayyurt B; Sari I; Cosgun Y; Bakir M
    J Cell Biochem; 2019 Sep; 120(9):15506-15517. PubMed ID: 31044455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Growth Characteristics of Crimean-Congo Hemorrhagic Fever Virus in Kidney Cells of Human and Bovine Origin.
    Földes K; Aligholipour Farzani T; Ergünay K; Ozkul A
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32630501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
    Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
    Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crimean-Congo hemorrhagic fever: seroprevalence and risk factors among humans in Achaia, western Greece.
    Sargianou M; Panos G; Tsatsaris A; Gogos C; Papa A
    Int J Infect Dis; 2013 Dec; 17(12):e1160-5. PubMed ID: 24084247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.